Related Experiment Video
Updated: Aug 16, 2026

Spectrophotometric Determination of Phycobiliprotein Content in Cyanobacterium Synechocystis
Published on: September 11, 2018
Experimental substantiation of the possibility of developing selenium- and iodine-containing pharmaceuticals based on
L M Mosulishvili1, E I Kirkesali, A I Belokobylsky
1EL Andronikashvili Institute of Physics, Georgian Academy of Sciences, Tamarashvili str 6, 380077, Tbilisi, Georgia.
Abstract:
The great potential of using blue-green algae Spirulina platensis as a matrix for the production of selenium- and iodine-containing pharmaceuticals is shown experimentally. The background levels of 31 major, minor and trace elements (Na, Mg, Al, Cl, K, Ca, Sc, V, Cr, Mn, Fe, Co, Ni (using (n,p) reaction), As, Br, Zn, Rb, Mo, Ag, Sb, I, Ba, Sm, Tb, Tm, Hf, Ta, W, Au, Hg, Th) in S. platensis biomass were determined by means of epithermal neutron activation analysis. The dependence of selenium and iodine accumulation in spirulina biomass on a nutrient medium loading of the above elements was characterized. To demonstrate the possibilities of determining toxic element intake by spirulina biomass, mercury was selected. The technological parameters for production of iodinated treatment-and-prophylactic pills are developed.
Related Concept Videos
Green Algae
Production of Pharmaceuticals

